Weight management supplements: the claims, the label and the build
In short
- A capsule, tablet or powder presented to help with weight is a medicine, usually listed. Its claims come from the Permissible Indications Determination: weight, body fat and metabolism in Part 1, appetite, satiety and dietary fat in Part 5.
- Every weight, body fat and metabolism claim in Part 1 needs scientific evidence. Traditional evidence isn't enough for any of them.
- A product indicated for weight loss carries the label statement "When used in conjunction with a program of reduced intake of dietary calories and increased physical activity". "Helps decrease/reduce body weight" and "Helps enhance/promote/increase weight loss" always carry it.
- A temporary weight loss claim must also say "Weight loss may not be maintained for longer than 3 months".
- Appetite claims must not imply or refer to eating disorders, and laxative claims must not refer to or imply weight loss.
Medicine, food or neither
A capsule or tablet that claims to help with weight loss or metabolism is presented for a therapeutic use, so it is a medicine. As a listed medicine (AUST L), every ingredient comes from the Permissible Ingredients Determination, every claim from the Permissible Indications Determination, and the sponsor holds the evidence for each claim (TGA listing).
A powder or bar sold as a food can't make those claims: it follows the Food Standards Code and its own health claim rules (food pathway). Which side a product falls on turns mostly on how it is presented, starting with its claims (medicine, food or cosmetic?).
The claims a listed medicine can make
The Therapeutic Goods (Permissible Indications) Determination (No. 1) 2025 sets the wording. Among the weight-related claims, all needing scientific evidence:
Weight (Part 1).
| Claim | Label statement |
|---|---|
| Helps decrease/reduce body weight | Always: the diet and activity statement |
| Helps enhance/promote/increase weight loss | Always: the diet and activity statement |
| Enhance/promote/increase temporary weight loss | "Weight loss may not be maintained for longer than 3 months", the diet and activity statement, and the others the item sets |
| Help maintain weight after weight loss | The diet and activity statement, if the product is indicated for weight loss |
| Helps in the maintenance of a healthy body weight | The same |
| Enhance/promote weight gain | None |
Body fat and composition (Part 1): "Helps enhance/promote/increase body fat loss", "Aids/assists abdominal fat loss", "Maintain/support abdominal fat loss", "Helps enhance/improve/promote/increase healthy body fat/muscle composition" and "Maintain/support healthy body fat/muscle composition", each with the diet and activity statement if the product is indicated for weight loss.
Metabolism (Part 1): "Helps improve/promote body metabolism/metabolic rate" and "Maintain/support body metabolism/metabolic rate", on the same terms.
Appetite, satiety and dietary fat (Part 5). "Helps regulate appetite" and "Maintain/support healthy appetite", whose presentation must not imply or refer to eating disorders; "Promote/enhance feeling of satiety"; and claims to help digest, eliminate or reduce the absorption of dietary fat, which take the diet and activity statement if the product is indicated for weight loss. These can rest on scientific or traditional evidence.
Each claim is used exactly as written, or with the options it allows, and the evidence must support the claim as the product makes it (permitted indications).
The limits
- The diet and activity statement. In full: "When used in conjunction with a program of reduced intake of dietary calories and increased physical activity." A weight loss product carries it on the label, so it is part of the pack design from the start (supplement labelling).
- Temporary weight loss. A product claiming temporary weight loss must say weight loss may not be maintained for longer than 3 months.
- Eating disorders. Appetite claims, including those about loss of appetite, must not imply or refer to eating disorders.
- Laxatives aren't weight loss products. Several bowel and laxative claims in Part 5 require that the presentation not refer to or imply weight loss.
- Advertising follows the listing. Every ad must stay within the Advertising Code and consistent with the ARTG entry, so a social post can't promise more than the label (TGA advertising).
How a weight management product is built
The claim comes first, because it decides the evidence, the dose and the label:
- The claim. Pick the exact wording, and check it against the evidence for each ingredient at its dose.
- The formula. Ingredients from the Permissible Ingredients Determination, within their limits and with any statements they require (permissible ingredients). Clinically studied, branded ingredients make the evidence clearer (branded ingredients).
- The evidence package. Scientific evidence for every weight, body fat and metabolism claim, held by the sponsor before listing.
- The label. The diet and activity statement and any others the claim requires, alongside everything TGO 116 asks for.
- Manufacture and stability. Licensed manufacture and a stability program supporting the shelf life (stability testing).
From our records
We haven't published a weight management case study. The way we build one is the same as these:
- EverLeanBody: a premium daily capsule for women 35 and over, built around affron®, a clinically studied saffron extract, with the claims evidence, the TGA listing, the label and a 24-month stability program. 5.8 months from signed brief to dispatch.
- A complex herbal capsule built around KSM-66® ashwagandha, with an evidence package covering more than 13 ingredients: design to production order in 32 days.
- The Belly Solution: a TGA-listed powder in a 14-day pouch, with a 36-month stability program, then a national pharmacy distribution trial.
Questions
Frequently asked questions
A listed medicine can, using the weight claims in Part 1 of the Permissible Indications Determination, with scientific evidence for each and the label statement "When used in conjunction with a program of reduced intake of dietary calories and increased physical activity".
Not for weight, body fat or metabolism claims: each of them in Part 1 needs scientific evidence. Some appetite, satiety and dietary fat claims in Part 5 can rest on scientific or traditional evidence.
"When used in conjunction with a program of reduced intake of dietary calories and increased physical activity." A temporary weight loss claim also needs "Weight loss may not be maintained for longer than 3 months".
A listed medicine can claim to help regulate appetite, maintain a healthy appetite or promote a feeling of satiety, but appetite claims must not imply or refer to eating disorders.
No. Several laxative claims in the Determination require that the product's presentation not refer to or imply weight loss.
Case studies
Case studies
Signed brief to dispatch in under six months
5.8 months from signed brief to dispatch
Read the story →Design to production order in 32 days
From design to production order in 32 days
Read the story →From a first product to a national pharmacy rollout
About eight months from formulation to dispatch
Read the story →Keep reading
Keep reading
How to start a supplement brand in Australia: the steps from idea to shelf
Starting a supplement brand in Australia, step by step: the pathway, ingredients and claims, the TGA sponsor, manufacturing, the label, the listing and launch.
How long does it take to develop a supplement?
How long it takes to develop a supplement, from our records: 32 days from design to production order at the fastest, the stages, and what holds a launch up.
Permitted indications: what a listed medicine can claim, and the evidence behind it
What a TGA-listed medicine can claim: the permitted indications, the evidence the sponsor must hold, the label statements and the advertising rules.
How much does it cost to develop a supplement in Australia?
Cost to develop a supplement in Australia: the development stages, the TGA's fees and charges for 2026–27, minimum orders, cost of goods and what adds to it.
Sources
General information, checked against these sources on 18 November 2026. It isn't advice on a particular product. Our work is from Take Friday Off's records.
- Therapeutic Goods (Permissible Indications) Determination (No. 1) 2025, Schedule 1, Part 1 (items 5, 55, 56, 58, 60, 66, 79, 82, 83, 84, 103, 105 and 123) and Part 5 (items 3, 10, 40, 58, 89, 105 and 127, and the laxative items' requirements), Federal Register of Legislation
- Applying the Advertising Code rules: general requirements, Therapeutic Goods Administration, as set out in our TGA advertising guide
